(19)
(11)
EP 2 994 130 A1
(12)
(43)
Date of publication:
16.03.2016
Bulletin 2016/11
(21)
Application number:
13884155.6
(22)
Date of filing:
06.05.2013
(51)
International Patent Classification (IPC):
A61K
31/405
(2006.01)
A61K
31/506
(2006.01)
A61K
31/513
(2006.01)
A61K
31/5025
(2006.01)
A61K
31/365
(2006.01)
A61K
31/496
(2006.01)
A61K
31/4709
(2006.01)
A61K
31/519
(2006.01)
A61K
31/403
(2006.01)
A61P
43/00
(2006.01)
(86)
International application number:
PCT/US2013/039758
(87)
International publication number:
WO 2014/182277
(
13.11.2014
Gazette 2014/46)
(84)
Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
(71)
Applicant:
Bush, Andrew B.
Princeton, New Jersey 08540 (US)
(72)
Inventor:
Bush, Andrew B.
Princeton, New Jersey 08540 (US)
(74)
Representative:
Care, Alison et al
Kilburn & Strode LLP 20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB)
(54)
FGF MODULATION OF IN VIVO ANTIBODY PRODUCTION AND HUMORAL IMMUNITY